Edition:
United Kingdom

IP Group PLC (IPO.L)

IPO.L on London Stock Exchange

133.20GBp
22 Jan 2018
Change (% chg)

-1.40 (-1.04%)
Prev Close
134.60
Open
134.80
Day's High
134.80
Day's Low
131.20
Volume
585,021
Avg. Vol
1,023,984
52-wk High
200.50
52-wk Low
109.10

Chart for

About

IP Group plc (IP Group) is a United Kingdom-based intellectual property commercialization company. The Company develops intellectual property-based businesses. The Company operates through three business segments: University partnership business, Venture capital fund management and In-licensing activity. The Company's University... (more)

Overall

Beta: 0.80
Market Cap(Mil.): £978.00
Shares Outstanding(Mil.): 699.07
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 135.25 16.58
EPS (TTM): -- -- --
ROI: -- 6.05 10.60
ROE: -- 10.96 14.19

BRIEF-IP Group Says Autifony Therapeutics Signs 627.5 Mln Euros Collaboration Deal With Boehringer Ingelheim​

* ‍PORTFOLIO COMPANY AUTIFONY THERAPEUTICS SIGNS EUR 627.5 MILLION COLLABORATION AGREEMENT WITH BOEHRINGER INGELHEIM​ Source text for Eikon: Further company coverage:

18 Dec 2017

BRIEF-IP Group ‍welcomes Touchstone Innovations' recommendation to shareholders to accept offer​

* ‍WELCOMES ANNOUNCEMENT MADE BY TOUCHSTONE INNOVATIONS PLC RECOMMENDING THAT TOUCHSTONE SHAREHOLDERS ACCEPT OFFER​

18 Oct 2017

BRIEF-IP Group says Touchstone Innovations offer now unconditional

* IP GROUP PLC - ‍ACCEPTANCES IN EXCESS OF 96%; ACCEPTANCE CONDITION SATISFIED IN TOUCHSTONE INNOVATIONS DEAL​

18 Oct 2017

BRIEF-UK's CMA not to refer IP Group, Touchstone Innovations deal to phase II probe

* UK'S CMA - ‍ DECIDED NOT TO REFER IP GROUP, TOUCHSTONE INNOVATIONS DEAL TO PHASE 2 INVESTIGATION Further company coverage: (Bengaluru Newsroom)

17 Oct 2017

BRIEF-IP Group's Istesso announces positive outcome from P1 study

* ISTESSO ANNOUNCES POSITIVE OUTCOME FROM P1 STUDY Source text for Eikon: Further company coverage:

30 Aug 2017

BRIEF-UK'S CMA says considering IP Group-Touchstone Innovations deal

* UK'S CMA SAYS CONSIDERING WHETHER OR NOT THAT ANTICIPATED ACQUISITION BY IP GROUP OF TOUCHSTONE INNOVATIONS WILL RESULT IN CREATION OF RELEVANT MERGER SITUATION (Bengaluru Newsroom: +91 80 6749 1136)

29 Aug 2017

BRIEF-IP Group updates on offer for Touchstone, capital raising

* PROPOSED TRANSACTION IN FINAL STAGES OF PRE-NOTIFICATION PROCESS WITH CMA FOLLOWING WHICH FORMAL 40 BUSINESS DAY PHASE 1 REVIEW PERIOD BY CMA SHALL COMMENCE; ANTICIPATED TO OCCUR SHORTLY

25 Aug 2017

BRIEF-IP Group says Istesso has started Phase 2a trial for rheumatoid arthritis drug

* Istesso commences phase 2a for mbs2320 in rheumatoid arthritis and expands research and development collaboration with Janssen

22 Aug 2017

BRIEF-IP Group says Chinese investor blocked from taking stake in company

* IP Group has received confirmation from China's Beijing Galaxy World Group that they have not received necessary approvals to make investment in IP

17 Aug 2017

Earnings vs. Estimates